1. Introduction {#sec1-molecules-24-01053}
===============

American ginseng (*Panax quinquefolius* L.) is grouped into four categories: wild, wild-simulated, woods-grown, and field-grown \[[@B1-molecules-24-01053],[@B2-molecules-24-01053]\]. The herb growing in its native habitat is called wild American ginseng. Wild-simulated American ginseng (WsAG) refers to a method of growing ginseng in a hardwood forest environment under natural conditions without any other human intervention \[[@B2-molecules-24-01053],[@B3-molecules-24-01053],[@B4-molecules-24-01053]\]. As such, WsAG roots are indeed indistinguishable from the wild roots due to the similar characteristics. When the seeds are planted in hardwood forests, and are grown in prepared rows or beds, or with removed ground vegetation or fertilizer and pesticides being available \[[@B5-molecules-24-01053],[@B6-molecules-24-01053],[@B7-molecules-24-01053]\], it is called as wood-grown ginseng. This variety of American ginseng requires 6 to 9 years to mature before harvesting \[[@B8-molecules-24-01053]\]. Different from wild-simulated category, the quality of wood-grown ginseng is between that of the wild and field-grown categories. That means, wood-grown American ginseng cannot be considered a substitute of the wild one. Field-grown American ginseng (FgAG), also called cultivated American ginseng, is intensely cultivated under artificial shade structures using fertilizers and pesticides \[[@B4-molecules-24-01053],[@B9-molecules-24-01053]\]. Generally speaking, FgAG is harvested after 3--4 years, while WsAG is collected at least after 10--20 years or longer \[[@B10-molecules-24-01053]\].

Modern pharmacological studies have shown that American ginseng has immunomodulatory \[[@B11-molecules-24-01053]\], anti-tumor \[[@B12-molecules-24-01053]\], anti-fatigue \[[@B13-molecules-24-01053],[@B14-molecules-24-01053]\], anti-diabetic \[[@B15-molecules-24-01053],[@B16-molecules-24-01053],[@B17-molecules-24-01053]\], anti-oxidant effects \[[@B18-molecules-24-01053]\] and the functions of improving impaired memory and learning functions \[[@B14-molecules-24-01053],[@B19-molecules-24-01053]\], etc. Furthermore, it is the traditional belief that roots from the wild are more medicinally efficacious, more potent and more valuable than those from cultivated sources, and wild roots thus command much higher prices on the Chinese medicine market \[[@B20-molecules-24-01053],[@B21-molecules-24-01053],[@B22-molecules-24-01053]\]. But, since the late 18th century, natural wild American ginseng resources suffered a sharp decline due to predatory exploitation in North America under the influence of economic interests, and are nearing extinction now \[[@B23-molecules-24-01053]\]. Meanwhile WsAG, with high quality and four to ten times the retail value of field-grown roots, is similar to the wild one \[[@B4-molecules-24-01053]\]. Actually, planting wild-simulated ginseng is encouraged with the aim of reducing harvest pressure on wild populations \[[@B24-molecules-24-01053]\]. Wild and wild-simulated roots could share the same export and trade regulations due to the similar morphology phenotype and market value \[[@B8-molecules-24-01053],[@B25-molecules-24-01053]\]. Recently, because the so-called wild-simulated American ginseng could capitalize on the premium paid for wild-appearing roots, and the species appeared well suited to the practice of forest farming, American ginseng has been recommended as an agroforestry crop candidate \[[@B26-molecules-24-01053]\]. With the continuous expansion of the folk and clinical applications of American ginseng, it is necessary to conduct an in-depth study on the chemical constituents of American ginseng aiming to clarify the material basis of efficacy. So far, there are a few comparative analysis on FgAG and wild American ginseng \[[@B27-molecules-24-01053],[@B28-molecules-24-01053]\]. These results showed that ginsenosides are different between them \[[@B26-molecules-24-01053]\], especially, the ratios of Rg~1~/Rd, Rg~1~/Rb~1~ and (Rg~1~ + Re)/Rd are characteristic markers for differentiating these two groups \[[@B28-molecules-24-01053]\]. However, a comparative study on the chemical composition between FgAG and WsAG does not exist.

Untargeted metabolomics, being able to profile diverse classes of metabolites, has been successfully applied to compare and identify the overall small-molecule components of different groups of samples \[[@B29-molecules-24-01053]\]. Ultra-high performance liquid chromatography (UPLC) combined with quadrupole time-of-flight tandem mass spectrometry (QTOF-MS) and multivariate statistical analyses are often applied to profile the different groups. For multivariate statistical analyses, principal component analysis (PCA) and orthogonal partial least squares discriminant analysis (OPLS-DA) are the most common statistical methods. Meanwhile, UPLC-QTOF-MS combined with the automated data processing software UNIFI was often applied recently in the characterization of chemical components of herbal medicines \[[@B30-molecules-24-01053],[@B31-molecules-24-01053],[@B32-molecules-24-01053],[@B33-molecules-24-01053],[@B34-molecules-24-01053],[@B35-molecules-24-01053]\]. When the coeluting constituents possessed different *m*/*z* values, HR-MS can provide a specific and accurate mass. While, UNIFI, a highly comprehensive, high throughput, efficient and simple platform, offers a method for integrating data acquisition, data mining, library searching and reporting generation.

Aiming to find out the similarities and differences between FgAG and WsAG, and to provide a reference for quality control and material basis of efficacy, the screening and the comparative analysis of chemical constituents in FgAG and WsAG is conducted for the first time in this paper. The shared constituents would be evaluated with the UPLC-QTOF-MS method combined with UNIFI. The characteristic components were to be found using the untargeted metabolomics method. The results will also be helpful in explaining the different pharmacological activities and controlling the quality of FgAG and WsAG.

2. Results {#sec2-molecules-24-01053}
==========

2.1. Identification of Components from FgAG and WsAG Based on the UNIFI Platform {#sec2dot1-molecules-24-01053}
--------------------------------------------------------------------------------

As a result of our screening analysis, a total of 121 compounds were identified or tentatively characterized in both positive and negative mode from FgAG and WsAG ([Table 1](#molecules-24-01053-t001){ref-type="table"}), the base peak intensity (BPI) chromatograms are shown in [Figure 1](#molecules-24-01053-f001){ref-type="fig"}, and their chemical structures are shown in [Figure 2](#molecules-24-01053-f002){ref-type="fig"}.

In FgAG and WsAG, these compounds were all shared constituents, including 47 protopanaxdiol-type saponins, 23 protopanaxtriol-type saponins, 15 oleanane- type saponins, 10 ocotillol-type saponins, one ursane, one flavonoid, one lignin, 12 organic acids and organic acid esters, three steroids, and eight other compounds.

2.2. Biomarker Discovery for FgAG and WsAG {#sec2dot2-molecules-24-01053}
------------------------------------------

The QC injections were clustered tightly in PCA indicating a satisfactory stability of the system. The PCA 2D plots of the samples from FgAG and WsAG groups were classified into two clusters according to their common spectral characteristics ([Figure 3](#molecules-24-01053-f003){ref-type="fig"}), with the FgAG samples of different years clustered into one group, while the WsAG samples were clustered into another group. The FgAG and WsAG samples were clearly separated, indicating that these two herb species could be easily differentiated.

After OPLS-DA plots ([Figure 4](#molecules-24-01053-f004){ref-type="fig"}A and [Figure 5](#molecules-24-01053-f005){ref-type="fig"}A) in both negative and positive modes were generated, the maximum separation between MsAG and FgAG groups was available. In the sufficient permutation test, the lines of grouping samples were significantly located underneath the random sampling lines ([Figure 4](#molecules-24-01053-f004){ref-type="fig"}B and [Figure 5](#molecules-24-01053-f005){ref-type="fig"}B), which indicated a fine validity for the following characteristic metabolites biomarkers identification \[[@B42-molecules-24-01053]\]. S-plots were then created to explore the potential chemical markers that contributed to the differences. Based on *p* values (*p* \< 0.05) and VIP values (VIP \> 3) \[[@B30-molecules-24-01053],[@B61-molecules-24-01053]\] from univariate statistical analysis, 22 robust known biomarkers enabling the differentiation between FgAG and WsAG, were marked and listed ([Figure 4](#molecules-24-01053-f004){ref-type="fig"}C and [Figure 5](#molecules-24-01053-f005){ref-type="fig"}C and [Table 2](#molecules-24-01053-t002){ref-type="table"}). Additionally, a heatmap was generated from these biomarkers in order to systematically evaluate the biomarkers ([Figure 6](#molecules-24-01053-f006){ref-type="fig"}), which visually showed the intensities of potential biomarkers between two species.

3. Discussion {#sec3-molecules-24-01053}
=============

In the screening analysis, 121 compounds were characterized in FgAG and WsAG, respectively. The results showed that both of these kinds of American ginseng were rich in natural components. These 121 compounds were all shared constituents in FgAG and WsAG, which means that they were similar in terms of the kinds of compound they contained. It has been reported that there are high ginsenoside contents in American ginseng. In this study, ginsenosides were also the main chemical components. Besides the most common dammarane-type and oleanane-type saponins, the ocotillol-type saponins are also occupying a notable proportion. The ocotillol-type is the characteristic type of saponin enabling American ginseng to be differentiated from Asian ginseng. So far, the studies on the mechanism of biosynthesis were focused on dammarane-type and oleanane-type ginsenosides. For example, dammaranediol was obtained by DS (dammarenediol synthase), and then modified by CYP450 to obtain dammarane-type saponins. Another example, oleanane-type ginsenosides were obtained by modifing *β*-amyrin with CYP450 and UGT (UDP-glycosyltransferase). Actually, there were little literature about the mechanism of ocotillol-type ginsenoside biosynthesis. The phytochemicals in WsAG and FgAG might provide a material basis for mechanistic studies. In short, this comprehensive and unique phytochemical profile study revealed the structural diversity of secondary metabolites and the similar patterns in FgAG and WsAG.

Furthermore, in non-targeted metabolomic analysis, when taking the contents of the constituents into account, it was found that there indeed existed quite a few differences between FgAG and WsAG, and 22 robust known biomarkers enabling the differentiation were discovered. This study illustrated the differences between FgAG and WsAG, and provided a basis for explaining the effect of different growth environments on secondary metabolites. For WsAG, there are 12 potential biomarkers, including two ocotillol-type saponins (**12**, **47**), two steroids (**22**, **117**), six damarane-type saponins (**21**, **35**, **37**, **42**, **44**, **112**), one oleanane-type saponin (**102**) and one other compound (**6**). The contents of these 12 components in WsAG were much greater than in FgAG. On the other hand, for FgAG, there are 10 potential biomarkers including two organic acids (**105, 115**), six damarane-type saponins (**13, 14, 31, 46, 81, 91, 99**), one oleanane-type saponin (**46**), and one ursane (**70**), which contents in FgAG were much greater than in WsAG. It has been reported that wild American ginseng has better biological activity than the FgAG. As is known, biological activity is caused by the high contents of phytochemicals. Correlation studies between potential markers and biological activities could be performed in the future.

Even so, there are still several unresolved issues. For example, as shown in BPI chromatograms, though 121 compounds were identified, there are still some unidentified components. Further research should be carried on based on the formula of these unknown compounds.

4. Materials and Methods {#sec4-molecules-24-01053}
========================

4.1. Materials and Reagents {#sec4dot1-molecules-24-01053}
---------------------------

Twenty eight batches of commercially available FgAGs and WsAGs root products were collected or purchased from different cultivation areas in China and American, including 20 batches of FgAGs and eight batches of WsAGs. A detailed sample list is provided in [Table 2](#molecules-24-01053-t002){ref-type="table"}.

For FgAGs, six roots of each sample were selected for analysis, while for WsAGs, 2--3 roots of each sample were analyzed. All the herbs were authenticated by the authors and the corresponding voucher specimens have been deposited in the Research Center of Natural Drug, School of Pharmaceutical Sciences, Jilin University, China.

A total of 25 saponins were isolated in our laboratory and identified by spectroscopic data. Among of these saponins, ginsenoside Ro \[[@B69-molecules-24-01053]\], 15 ginsenosides \[[@B70-molecules-24-01053],[@B71-molecules-24-01053]\] (Rb~1~, Rb~2~, Rb~3~, Rc, Rd, Re, 20(*S*)-Rg~3~, 20(*R*)-Rg~3~, 20(*S*)-Rh~2~, Rg~1~, 20(*R*)-Rg~2~, 20(*S*)-Rh~1~, 20(*R*)-Rh~1~, pseudo-ginsenoside F~11~, pseudo-ginsenoside RT~5~) and another six saponins \[[@B71-molecules-24-01053]\] (quinquenoside L~8~, L~9~, L~11~, F~3~, 24(*S*)-pseudo- ginsenoside *F~11~*, gypenoside XVII) were isolated and identified by our group.

Oleanolic acid-28-*O*-*β*-[d]{.smallcaps}-glucopyranoside, ginsenoside Rs~1~, -Rs~2~ and methyl gallate-3-*O*-*β*-[d]{.smallcaps}-glucoside were also isolated in our laboratory and identified by NMR spectroscopy. Adenosine, α-maltose, [l]{.smallcaps}-tryptophan, notoginsenoside R~1~, kaempferol, [l]{.smallcaps}-phenylalanine, sucrose, palmitoleic acid, quinic acid and α-linolenic acid were purchased from Beijing Zhongke Quality Inspection Biotechnology Co., Ltd. (Beijing, China).

Acetonitrile and methanol suitable for UPLC-MS were purchased from Fisher Chemical Company (Geel, Belgium). Formic acid was purchased from Sigma-Aldrich Company (St. Louis, MO, USA). Deionized water was purified using a Millipore water purification system (Millipore, Billerica, MA, USA). All other chemicals were of analytical grade.

4.2. Sample Preparation and Extraction {#sec4dot2-molecules-24-01053}
--------------------------------------

All samples were respectively air-dried, grinded and sieved (Chinese National Standard Sieve No. 3, R40/3 series) to get a homogeneous powder. Then each fine powder was accurately weighed (0.2 g) and soaked with 10 mL of methanol overnight. On the second day, each powder was extracted in an ultrasonic bath (power of 250 W, frequency of 40 kHz) for half an hour. After cooling to room temperature, the lost weight was replenished with methanol. After filtering through a syringe filter (0.22 μm), the extracts were injected directly into the UPLC system. In addition, to ensure the stability and suitability consistency of MS analysis, a quality control (QC) sample was prepared by pooling the same volume (50 μL) from every sample and five QC injections were performed randomly through the whole worklist. The volumes injected for samples and QC were all 5 μL for each run.

4.3. UPLC-QTOF-MS {#sec4dot3-molecules-24-01053}
-----------------

UPLC-QTOF-MS^E^ analysis was performed on a Waters Xevo G2-XS QTOF mass spectrometer (Waters Co., Milford, MA, USA) equipped with a UPLC system through an electrospray ionization (ESI) interface. Chromatographic separation was performed on an ACQUITY UPLC BEH C~18~ (100 mm × 2.1 mm, 1.7 μm) from Waters Corporation (Milford, MA, USA). The mobile phases were composed of eluent A (0.1% formic acid in water, *v*/*v*) and eluent B (0.1% formic acid in acetonitrile, *v*/*v*) with flow rate of 0.4 mL/min. The elution conditions applied were: 0→2 min, 10% B; 2→26 min, 10\~100% B; 26→29 min, 100% B; 29→29.1 min, 100\~10% B; 29.1→32 min, 10% B. The temperature of the autosampler and the UPLC column manager were set at 15 °C and 30 °C respectively. Mixtures of 90/10 and 10/90 water/acetonitrile were used as the weak wash solvent and the strong wash solvent respectively. The mass spectrum was acquired from 100 to 1500 Da in MS^E^ mode. The positive mode conditions were: capillary voltage, 2.6 kV; cone voltage, 40 V; source temperature, 150 °C; desolvation temperature, 400 °C; cone gas flow, 50 L/h; desolvation gas flow, 800 L/h. Negative mode conditions were identical to the positive mode conditions except for capillary voltage (2.2 kV). In MS^E^ mode, data acquisition was performed via the mass spectrometer by rapidly switching from a low-collision energy (CE) scan to a high-CE scan during a single LC run. The low energy function was set to 6 V, while ramp collision energy of high energy function was set to 20\~40 V. Leucine enkephalin (*m*/*z* 556.2771 in positive mode and 554.2615 in negative mode) was used as external reference of Lock Spray™ infused at a constant flow of 10 μL/min. During acquisition, data were collected in continumn mode for the screening analysis, and in centroid mode for the metabolomics analysis.

4.4. Chemical Information Database for the Components of FgAG and WsAG {#sec4dot4-molecules-24-01053}
----------------------------------------------------------------------

Besides the in-house Traditional Medicine Library in the UNIFI software, a systematic investigation of chemical components was conducted \[[@B34-molecules-24-01053]\]. A self-built database of compounds that were isolated from FgAG and WsAG was established by searching online databases or internet search engines such as PubMed, Full-Text Database (CNKI), ChemSpider, Web of Science and Medline. Chemical information including the component name, molecular formula and structure of the components from the herbs were obtained from the database \[[@B56-molecules-24-01053]\].

4.5. The Screening Analysis by the UNIFI Platform {#sec4dot5-molecules-24-01053}
-------------------------------------------------

To quickly identify the chemical compounds, the MS raw data, compressed with Waters Compression and Archival Tool v1.10, was automatically screened and identified by using the streamlined workflow of UNIFI 1.7.0 software (Waters, Manchester, UK) \[[@B30-molecules-24-01053]\]. The parameters were as follows: the minimum peak area of 200 was set for 2D peak detection; the peak intensity of low energy over 1000 counts and the peak intensity of high energy over 200 counts were selected for 3D peak detection. Mass error up to ±5 ppm for identified compounds, retention time in the range of ±0.1 min was allowed to match the reference substance. The matching compounds would be generated predicted fragments from structure. The negative adducts containing +COOH and -H and positive adducts containing +H and +Na were selected in the analysis. Leucine-enkephalin was selected as the reference compound, and \[M − H\]^−^ 554.2620 was used for negative ion and \[M + H\]^+^ 556.2766 was used for positive ion \[[@B72-molecules-24-01053]\].

4.6. The Metabolomics Analysis {#sec4dot6-molecules-24-01053}
------------------------------

The raw data were processed by MarkerLynx XS V4.1 software (Waters, Milford, CT, USA) for alignment, deconvolution, data reduction, etc. \[[@B73-molecules-24-01053]\]. A MarkerLynx processing method was firstly created, and the main parameters were as follows: retention time range 0--26 min, mass range 100--1500 Da, mass tolerance 0.10, minimum intensity 5%, mass window 0.10, retention time window 0.20, marker intensity threshold 2000 counts and noise elimination level 6. After processing the data, the results could be showed in the Extended Statistics (XS) Viewer. *m*/*z*-RT pairs with corresponding intensities for all the detected peaks from each data file were listed. The same value of RT and *m*/*z* in different batched of samples were regarded as the same component. Then, multivariate statistical analysis was performed. Firstly, principal component analysis (PCA) was used to show the pattern recognition and maximum variation aiming to obtain the overview and classification. Secondly, orthogonal projections to latent structures discriminant analysis (OPLS-DA) in both positive and negative modes was performed in order to get the maximum separation between MsAG and FgAG group and to explore the potential chemical markers that contributed to the differences. Then, S-plots was created to provide visualization of the OPLS-DA predictive component loading to facilitate model interpretation. Meawhile, variable importance for the projection (VIP) was helpful to screen the different components, and the metabolites with VIP value (\>3.0) were considered as potential markers \[[@B29-molecules-24-01053]\]. In addition, the permutation test was performed to provide reference distributions of the R^2^/Q^2^-values that could indicate the statistical significance \[[@B30-molecules-24-01053],[@B31-molecules-24-01053],[@B32-molecules-24-01053],[@B33-molecules-24-01053]\]. Simca 15.0 software (Umetrics, Malmö, Sweden) was used to show the analysis results \[[@B56-molecules-24-01053],[@B74-molecules-24-01053]\].

5. Conclusions {#sec5-molecules-24-01053}
==============

In a comprehensive and unique phytochemical profile study, a total of 121 chemical compounds with different structural types were identified from WsAG and FgAG. The structural patterns included protopanaxdiol-type saponins, protopanaxtriol-type saponins, ocotillol-type saponins, oleanane-type saponins and other glyosides, organic acid and organic acid esters, steroids, etc. The results showed that WsAG and FgAG were rich in natural components. Furthermore, these 121 compounds were all shared constituents in them, meaning that they were similar in the kinds of compounds they contain. In metabolomic analysis, it was found that there indeed existed several differences in the contents of the constituents between FgAG and WsAG, and 22 robust known biomarkers enabling the differentiation were discovered. In a word, the results will fill the data gap in the study on the chemical constituents of WsAG and provide a reference for quantitative determinations in its quality control.

**Sample Availability:** Samples of the compounds are not available from the authors.
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![The representative base peak intensity (BPI) chromatograms of FgAG and WsAG in negative and positive modes.](molecules-24-01053-g001){#molecules-24-01053-f001}

###### 

Chemical structures of compounds identified in FgAG and WsAG.
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![The PCA of FgAG and WsAG in positive mode and negative mode.](molecules-24-01053-g003){#molecules-24-01053-f003}

![The OPLS-DA (**A**); permutation tests (**B**) and S-plot (**C**) in negative mode.](molecules-24-01053-g004){#molecules-24-01053-f004}

![The OPLS-DA (**A**); permutation tests (**B**) and S-plot (**C**) in positive mode.](molecules-24-01053-g005){#molecules-24-01053-f005}

![The heatmap visualizing the intensities of potential biomarkers.](molecules-24-01053-g006){#molecules-24-01053-f006}

molecules-24-01053-t001_Table 1

###### 

Compounds identified from FgAG and WsAG by UPLC-QTOF-MS^E^.

  --------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------
  No.        t~R~ (min)   Formula              Calculated Mass (Da)   TheoreticalMass (Da)   Mass Error (ppm)   MS^E^ Fragmentation                                                                                                                                                                                                                           Identification                                               Sources         Ref.
  ---------- ------------ -------------------- ---------------------- ---------------------- ------------------ --------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------- ------------------------------------------------------------ --------------- ---------------------------------------------------------
  1          0.57         C~7~H~12~O~6~        192.0636               192.0634               1.0                191.0563\[M − H\]^−^, 173.0454\[M − H-H~2~O\]^−^, 127.0407\[M − H-H~2~O-HCOOH\]^−^, 109.0452\[M − H-2H~2~O-HCOOH\]^−^, 91.0352\[M − H-3H~2~O-HCOOH\]^−^                                                                                       Quinic acid                                                  WsAG, FgAG      s

  2          0.64         C~12~H~22~O~11~      342.1162               342.1165               0.8                341.1092\[M − H\]^−^, 179.0562\[M − H-Glu\]^−^                                                                                                                                                                                                *α*-Maltose                                                  WsAG, FgAG      s

  3          0.77         C~10~H~13~N~5~O~4~   267.0959               267.0968               −3.3               268.1031\[M+H\]^+^, 237.0874\[M + H-CH~2~OH\]^+^, 226.0898\[M + H-CN~2~H~2~\]^+^, 136.0612\[M + H-Rib\]^+^, 130.0495\[M + H-CH~2~OH-C~4~N~4~H~3~\]^+^                                                                                         Adenosine                                                    WsAG, FgAG      s

  4          0.93         C~12~H~22~O~11~      342.1168               342.1162               1.7                341.1095\[M − H\]^−^, 287.1097\[M − H-3H~2~O\]^−^, 179.0563\[M − H-Glu\]^−^                                                                                                                                                                   Sucrose                                                      WsAG, FgAG      s

  5          0.95         C~9~H~11~NO~2~       165.0777               165.0782               −3.0               166.0850\[M + H\]^+^, 150.0589\[M + H-NH~2~\]^+^, 132.0486\[M + H-H~2~O-NH~2~\]^+^, 120.0807\[M + H-HCOOH\]^+^, 91.0559\[M + H-CH-NH~2~-HCOOH\]^+^                                                                                            L-Phenylalanine                                              WsAG, FgAG      s

  6 \*       1.02         C~14~H~18~O~10~      346.0903               346.0900               1.0                345.0830\[M − H\]^−^, 327.0598\[M − H-H~2~O\]^−^, 309.0728\[M − H-2H~2~O\]^−^, 165.0195\[M − H-Glu\]^−^, 150.0115\[M − H-Glu-CH~3~\]^−^                                                                                                       Methyl gallate 3-*O*-*β*-[d]{.smallcaps}-glucoside           WsAG \> FgAG\   s
                                                                                                                                                                                                                                                                                                                                                                                                                           VIP: 14.18\     
                                                                                                                                                                                                                                                                                                                                                                                                                           *p* \< 0.001    

  7          1.51         C~11~H~12~N~2~O~2~   204.0899               204.0899               −0.1               203.0826\[M − H\]^−^, 141.0660\[M − H-HCOOH-NH~2~\]^−^, 129.0506\[M − H-C~3~H~6~O~2~\]^−^                                                                                                                                                     L-Tryptophane                                                WsAG, FgAG      s

  8          4.71         C~17~H~20~O~9~       368.1106               368.1107               −0.4               367.1033\[M − H\]^−^, 191.0754\[M − H-C~10~H~9~O~3~\]^−^, 193.0466\[M − H-GluA\]^−^, 177.0758\[M − H-GluA-CH~3~\]^−^, 127.0350\[M − H-GluA-H~2~O-OCH~3~\]^−^                                                                                  3-*O*-trans-Feruloylquinic Acid                              WsAG, FgAG      \[[@B36-molecules-24-01053]\]

  9          4.92         C~48~H~82~O~19~      962.5440               962.5450               −1.0               1007.5432\[M + HCOO\]^−^, 763.2898\[M − H-2H~2~O-Glu\]^−^, 815.4784\[M − H-Rha\]^−^, 781.3155\[M − H-Glu\]^−^, 635.2307\[M − H-Glu-Rha-H~2~O\]^−^, 437.1863\[M − H-2Glu-Rha-3H~2~O\]^−^                                                       Majoroside F~6~                                              WsAG, FgAG      \[[@B37-molecules-24-01053]\]

  10         5.18         C~36~H~58~O~8~       618.4130               618.4132               −0.3               619.4203\[M + H\]^+^, 439.3712\[M + H-Glu\]^+^, 422.3451\[M + H-Glu-OH\]^+^, 383.2823\[M + H-Glu-C~4~H~8~\]^+^, 297.2336\[M + H-Glu-C~9~H~16~O\]^+^                                                                                           Oleanolic acid -28-*O*-*β*-[d]{.smallcaps}-glucopyranoside   WsAG, FgAG      s

  11         5.32         C~48~H~82~O~20~      978.5399               978.5397               −0.3               1023.5379\[M + HCOO\]^−^, 997.5331\[M − H\]^−^,815.4972\[M − H-Glu\]^−^, 797.4718\[M − H-Glu-H~2~O\]^−^, 653.3389\[M − H-2Glu\]^−^, 491.2724\[M − H-3Glu\]^−^                                                                                 Yesanchinoside B                                             WsAG, FgAG      \[[@B38-molecules-24-01053]\]

  12 \*      5.54         C~47~H~80~O~19~      948.5305               948.5294               1.2                993.5270\[M + HCOO\]^−^, 815.4921\[M − H-Ara\]^−^, 653.3392\[M − H-2Glu-Ara\]^−^, 473.3030\[M − H-2Glu-Ara\]^−^, 455.3922\[M − H-2Glu-Ara-H~2~O\]^−^, 391.2582\[M − H-2Glu-Ara-C~6~H~12~O\]^−^                                                Yesanchinoside C                                             WsAG \> FgAG\   \[[@B38-molecules-24-01053]\]
                                                                                                                                                                                                                                                                                                                                                                                                                           VIP: 6.18\      
                                                                                                                                                                                                                                                                                                                                                                                                                           *p* \< 0.001    

  13 ^\#^    5.78         C~48~H~82~O~19~      962.5443               962.5450               −1.0               1007.5436\[M + HCOO\]^−^, 961.5388\[M − H\]^−^, 799.4784\[M − H-Glu\]^−^, 637.2307\[M − H-2Glu\]^−^, 475.5863\[M − H-3Glu\]^−^                                                                                                                Notoginsenoside N                                            WsAG \< FgAG\   \[[@B39-molecules-24-01053]\]
                                                                                                                                                                                                                                                                                                                                                                                                                           VIP: 11.83\     
                                                                                                                                                                                                                                                                                                                                                                                                                           *p* \< 0.001    

  14 ^\#^    5.94         C~42~H~74~O~15~      818.5031               818.5028               0.4                863.5006\[M + HCOO\]^−^, 667.4323\[M − H-Rha\]^−^, 533.2329\[M − H-C~6~H~13~O~2~-C~11~H~19~O\]^−^, 506.3845\[M − H-Glu-Rha\]^−^, 477.2169\[M − H-C~20~H~36~O~4~\]^−^                                                                          Quinquenoside L~9~                                           WsAG \< FgAG\   s
                                                                                                                                                                                                                                                                                                                                                                                                                           VIP: 7.20\      
                                                                                                                                                                                                                                                                                                                                                                                                                           *p* = 0.0002    

  15         5.94         C~42~H~72~O~14~      800.4915               800.4922               −0.9               801.4988\[M + H\]^+^, 621.4983\[M + H-Glu-H~2~O\]^+^, 459.3659\[M + H-2Glu\]^+^, 423.3450\[M + H-2Glu-3H~2~O\]^+^                                                                                                                             Majoroside F~2~                                              WsAG, FgAG      \[[@B40-molecules-24-01053]\]

  16         6.25         C~26~H~34~O~11~      522.2097               522.2101               −0.7               567.2079\[M + HCOO\]^−^, 521.2204\[M − H\]^−^, 458.2935\[M − H-H~2~O-C~2~H~5~O\]^−^, 341.1396\[M − H-Glu-H~2~O\]^−^, 178.0559\[M − H-C~20~H~23~O~5~\]^−^                                                                                      Urolignoside                                                 WsAG, FgAG      \[[@B41-molecules-24-01053]\]

  17         6.48         C~54~H~92~O~23~      1108.6034              1108.6029              0.4                1153.6016\[M + HCOO\]^−^, 961.5452\[M − H-Rha\]^−^, 799.4902\[M − H-Glu-Rha\]^−^, 637.2950\[M − H-2Glu-Rha\]^−^, 475.2681\[M − H-3Glu-Rha\]^−^                                                                                                Yesanchinoside E                                             WsAG, FgAG      \[[@B42-molecules-24-01053]\]

  18         6.77         C~47~H~80~O~18~      932.5348               932.5345               0.3                977.5318\[M + HCOO\]^−^, 931.5271\[M − H\]^−^, 799.4697\[M − H-Ara\]^−^, 769.4734\[M − H-Glu\]^−^, 637.3146\[M − H-Glu-Ara\]^−^                                                                                                               Quinquenoside F~6~                                           WsAG, FgAG      \[[@B37-molecules-24-01053]\]

  19         6.88         C~48~H~82~O~19~      962.5450               962.5450               −0.1               1007.5432\[M + HCOO\]^−^, 859.4881\[M − H-C~5~H~10~O~2~\]^−^, 799.4204\[M − H-Glu\]^−^, 696.4328\[M − H-Glu-C~5~H~9~O\]^−^, 637.3158\[M − H-2Glu\]^−^, 601.2316\[M − H-2Glu-2H~2~O\]^−^                                                       Quinquenoside L~2~                                           WsAG, FgAG      \[[@B43-molecules-24-01053]\]

  20         7.01         C~42~H~72~O~14~      800.4914               800.4922               −1.0               845.4896\[M + HCOO\]^−^, 799.4836\[M − H\]^−^, 653.4319\[M − H-Rha\]^−^, 491.2475\[M − H-Glu-Rha\]^−^                                                                                                                                         (24*S*)-Pseudoginsenoside *F~11~*                            WsAG, FgAG      s

  21 \*      7.05         C~47~H~80~O~18~      932.5349               932.5345               0.4                977.5346\[M + HCOO\]^−^, 840.4930\[M − H-2H~2~O-C~4~H~7~\]^−^, 799.4859\[M − H-Xyl\]^−^, 769.4735\[M − H-Glu\]^−^, 637.4321\[M − H-Glu-Xyl\]^−^                                                                                               Notoginsenoside R~1~                                         WsAG \> FgAG\   s
                                                                                                                                                                                                                                                                                                                                                                                                                           VIP: 24.59\     
                                                                                                                                                                                                                                                                                                                                                                                                                           *p* \< 0.001    

  22 \*      7.10         C~28~H~48~O          400.3723               400.3705               4.3                423.3620\[M+Na\]^+^, 382.2862\[M + H-CH~3~\]^+^, 339.2934\[M + H-H~2~O-C~3~H~7~\]^+^, 255. 2948\[M + H-H~2~O-C~9~H~19~\]^+^                                                                                                                   Methylcholesta-7-en-3*β*-ol                                  WsAG \> FgAG\   \[[@B44-molecules-24-01053]\]
                                                                                                                                                                                                                                                                                                                                                                                                                           VIP: 4.69\      
                                                                                                                                                                                                                                                                                                                                                                                                                           *p* \< 0.001    

  23         7.12         C~48~H~82~O~19~      962.5435               962.5450               −1.5               1007.54171\[M + HCOO\]^−^, 961.5329\[M − H\]^−^, 799.3722\[M − H-Glu\]^−^, 637.4321\[M − H-2Glu\]^−^, 475.3722\[M − H-3Glu\]^−^, 391.4833\[M − H-3Glu-C~6~H~12~\]^−^                                                                          Notoginsenoside R~6~                                         WsAG, FgAG      \[[@B42-molecules-24-01053]\]

  24         7.25         C~47~H~80~O~18~      932.5335               932.5345               −1.0               977.5317\[M + HCOO\]^−^, 931.5282\[M − H\]^−^, 799.4701\[M − H-Xyl\]^−^, 673.3294\[M − H-Xyl-Glu\]^−^, 475.2148\[M − H-Xyl-2Glu\]^−^                                                                                                          Notoginsenoside ST5                                          WsAG, FgAG      \[[@B45-molecules-24-01053]\]

  25         7.29         C~54~H~90~O~24~      1122.5818              1122.5822              0.4                1167.5812\[M + HCOO\]^−^, 1121.5747\[M − H\]^−^, 959.5120\[M − H-Glu\]^−^, 797.4669\[M − H-2Glu\]^−^, 473.4334\[M − H-4Glu\]^−^                                                                                                               Quinquenoside IV                                             WsAG, FgAG      \[[@B42-molecules-24-01053]\]

  26         7.40         C~42~H~72~O~14~      800.4918               800.4922               −0.5               845.4900\[M + HCOO\]^−^, 784.4683\[M − H-CH~3~\]^−^, 637.4340\[M − H-Glu\]^−^, 471.3787\[M − H-2Glu\]^−^                                                                                                                                      Ginsenoside Rg~1~                                            WsAG, FgAG      s

  27         7.47         C~48~H~82~O~18~      946.5491               946.5501               −1.0               991.5473\[M + HCOO\]^−^, 945.5413\[M − H\]^−^, 783.5142\[M − H-Glu\]^−^, 637.4125\[M − H-Glu-Rha\]^−^, 475.5147\[M − H-2Glu-Rha\]^−^                                                                                                          Ginsenoside Re                                               WsAG, FgAG      s

  28         7.47         C~28~H~48~O          400.3715               400.3705               2.4                423.3617\[M+Na\]^+^, 401.3540\[M + H\]^+^, 383.2861\[M + H-H~2~O\]^+^, 325.2982\[M + H-H~2~O-CH~3~-C~3~H~7~\]^+^, 284.1420\[M + H-H~2~O-C~7~H~15~\]^+^, 175.1221\[M + H-H~2~O-C~15~H~28~\]^+^                                                 Campesterol                                                  WsAG, FgAG      a

  29         7.69         C~45~H~74~O~17~      886.4926               886.4925               −0.1               885.4853\[M − H\]^−^, 799.4748\[M − H-Mal\]^−^, 637.4303\[M − H-Mal-Glu\]^−^, 475.3751\[M − H-Mal-2Glu\]^−^                                                                                                                                   Malonyl-ginsenoside Rg~1~                                    WsAG, FgAG      \[[@B46-molecules-24-01053]\]

  30         7.85         C~42~H~72~O~14~      800.4929               800.4922               0.8                845.4911\[M + HCOO\]^−^, 799.4837\[M − H\]^−^, 653.3687\[M − H-Rha\]^−^, 491.2354\[M − H-Rha-Glu\]^−^                                                                                                                                         Quinquenoside L~11~                                          WsAG, FgAG      s

  31 ^\#^    7.84         C~51~H~84~O~21~      1032.5505              1032.5532              2.6                1031.5414\[M − H\]^−^, 945.5212\[M − H-Mal\]^−^, 783.4173\[M − H-Mal-Glu\]^−^, 637.4385\[M − H-Mal-Rha-Glu-Ac\]^−^, 475.3932\[M − H-Mal-2Glu-Rha\]^−^                                                                                         Malonyl-ginsenoside Re                                       WsAG \< FgAG\   \[[@B39-molecules-24-01053]\]
                                                                                                                                                                                                                                                                                                                                                                                                                           VIP: 5.65\      
                                                                                                                                                                                                                                                                                                                                                                                                                           *p* = 0.0060    

  32         7.94         C~47~H~80~O~19~      948.5282               948.5294               −1.2               947.5209\[M − H\]^−^, 815.4786\[M − H-Xyl\]^−^, 653.2758\[M − H-Glu-Xyl\]^−^, 491.1787\[M − H-2Glu-Xyl\]^−^                                                                                                                                   Vinaginsenoside R~6~                                         WsAG, FgAG      \[[@B39-molecules-24-01053]\]

  33         8.15         C~47~H~80~O~17~      916.5409               916.5396               1.4                961.5377\[M + HCOO\]^−^, 915.5306\[M − H\]^−^, 783.4819\[M − H-Ara\]^−^, 753.4732\[M − H-Glu\]^−^, 621.4290\[M − H-Ara-Glu\]^−^, 459.4687\[M − H-2Glu-Ara\]^−^                                                                                Quinquenoside L~14~                                          WsAG, FgAG      \[[@B47-molecules-24-01053]\]

  34         8.23         C~44~H~74~O~15~      842.4996               842.5028               −3.6               887.4978\[M + HCOO\]^−^, 841.4939\[M − H\]^−^, 799.4833\[M − H-Ac\]^−^, 695.4459\[M − H-Glu\]^−^, 653.4321\[M − H-Ac-Rha\]^−^, 684.3932\[M − H-CH~3~-C~8~H~14~O~2~\]^−^, 491.4219\[M − H-Rha-Glu-Ac\]^−^                                      Vinaginsenoside R~1~                                         WsAG, FgAG      \[[@B48-molecules-24-01053]\]

  35 \*      8.26         C~54~H~94~O~24~      1126.6162              1126.6135              2.4                1171.6110\[M + HCOO\]^−^, 1125.6094\[M − H\]^−^, 975.5349 \[M − H-Xyl-H~2~O\]^−^, 963.5502\[M − H-Glu\]^−^, 801.3547\[M − H-2Glu\]^−^, 831.3214\[M − H-Glu-Xyl\]^−^, 507.3214\[M − H-3Glu-Xyl\]^−^                                            Quinquenoside F~3~                                           WsAG \> FgAG\   s
                                                                                                                                                                                                                                                                                                                                                                                                                           VIP: 3.35\      
                                                                                                                                                                                                                                                                                                                                                                                                                           *p* \< 0.001    

  36         8.57         C~44~H~74~O~15~      842.5028               842.5012               −1.7               887.4995\[M + HCOO\]^−^, 841.4939\[M − H\]^−^, 637.4321\[M − H-Glu-Ac\]^−^, 475.3030\[M − H-2Glu-Ac\]^−^, 391.4158\[M − H-2Glu-Ac-C~6~H~11~\]^−^                                                                                              Acetyl-Ginsenoside Rg~1~                                     WsAG, FgAG      \[[@B39-molecules-24-01053]\]

  37 \*      8.59         C~41~H~70~O~13~      770.4808               770.4816               −1.0               815.4798\[M + HCOO\]^−^, 769.4722\[M − H\]^−^, 637.4321\[M − H-Ara\]^−^, 475.2678\[M − H-Ara-Glu\]^−^, 391.1748\[M − H-Ara-Glu-C~6~H~11~\]^−^                                                                                                 Notoginsenoside R~2~                                         WsAG \> FgAG\   \[[@B42-molecules-24-01053]\]
                                                                                                                                                                                                                                                                                                                                                                                                                           VIP: 4.83\      
                                                                                                                                                                                                                                                                                                                                                                                                                           *p* \< 0.001    

  38         8.63         C~48~H~82~O~19~      962.5423               962.5450               −2.7               1007.5405\[M + HCOO\]^−^, 961.5371\[M − H\]^−^, 815.4317\[M − H-Rha\]^−^, 799.4622\[M − H-Glu\]^−^, 653.4385\[M − H-Glu-Rha\]^−^, 617.4316\[M − H-Glu-Rha-H~2~O\]^−^, 491.2912\[M − H-2Glu-Rha\]^−^                                           Majoroside F~5~                                              WsAG, FgAG      \[[@B37-molecules-24-01053]\]

  39         8.64         C~30~H~48~O~2~       440.3646               440.3654               −1.9               441.3719\[M + H\]^+^, 423.3606\[M + H-H~2~O\]^+^, 339.2908\[M + H-HCOOH-C~4~H~8~\]^+^, 248.2948\[M + H-C~14~H~24~\]^+^, 203.1849\[M + H-HCOOH-C~14~H~24~\]^+^                                                                                 Deoxyoleanolic acid                                          WsAG, FgAG      \[[@B46-molecules-24-01053]\]

  40         8.78         C~48~H~80~O~18~      944.5338               944.5345               −0.6               989.5320\[M + HCOO\]^−^, 943.5250\[M − H\]^−^, 781.4541\[M − H-Glu\]^−^, 619.4143\[M − H-2Glu\]^−^, 457.5876\[M − H-3Glu\]^−^                                                                                                                 Quinquenoside L~1~                                           WsAG, FgAG      \[[@B49-molecules-24-01053]\]

  41         8.83         C~53~H~88~O~23~      1092.5718              1092.5716              0.2                1137.5696\[M + HCOO\]^−^, 1091.5641\[M − H\]^−^, 959.5571\[M − H-Xyl\]^−^, 929.4601\[M − H-Glu\]^−^, 797.4852\[M − H-Glu-Xyl\]^−^                                                                                                             Yesanchinoside G                                             WsAG, FgAG      \[[@B50-molecules-24-01053]\]

  42 \*      8.89         C~47~H~78~O~17~      914.5225               914.5239               −1.5               959.5225\[M + HCOO\]^−^, 913.5147\[M − H\]^−^, 733.2547\[M − H-H~2~O-Glu\]^−^, 619.4527\[M − H-Glu-Xyl\]^−^, 457.3254\[M − H-2Glu-Xyl\]^−^                                                                                                    Quinquenoside L~8~                                           WsAG \> FgAG\   s
                                                                                                                                                                                                                                                                                                                                                                                                                           VIP: 3.97\      
                                                                                                                                                                                                                                                                                                                                                                                                                           *p* = 0.0004    

  43         8.97         C~48~H~82~O~19~      962.5438               962.5450               −1.2               1007.5420\[M + HCOO\]^−^, 946.5212\[M − H-CH~3~\]^−^, 781.4533\[M − H-Glu-H~2~O\]^−^, 637.4321\[M − H-2Glu\]^−^, 475.3932\[M − H-3Glu\]^−^                                                                                                    Majoroside F~1~                                              WsAG, FgAG      \[[@B40-molecules-24-01053]\]

  44 \*      9.14         C~42~H~70~O~13~      782.4325               782.4816               1.2                781.4747\[M − H\]^−^, 619.4181\[M − H-Glu\]^−^, 457.4798\[M − H-2Glu\]^−^, 376.4797\[M − H-2Glu-C~6~H~9~\]^−^                                                                                                                                 Quinquenoside F~1~                                           WsAG \> FgAG\   \[[@B51-molecules-24-01053]\]
                                                                                                                                                                                                                                                                                                                                                                                                                           VIP: 4.10\      
                                                                                                                                                                                                                                                                                                                                                                                                                           *p* = 0.0004    

  45         9.27         C~15~H~10~O~6~       286.0480               286.0477               0.8                285.0407\[M − H\]^−^, 227.0521\[M − H-C~2~H~2~O~2~\]^−^, 151.0037\[M − H-C~8~H~6~O~2~\]^−^, 106.0148\[M − H-C~9~H~7~O~4~\]^−^, 112.0351\[M − H-C~9~H~5~O~5~\]^−^                                                                              Kaempferol                                                   WsAG, FgAG      s

  46 ^\#^    9.32         C~53~H~86~O~24~      1118.5514              1118.5509              0.5                1117.5436\[M − H\]^−^, 1040.5481\[M − H-CH~3~OH\]^−^, 955.3219\[M − H-Glu\]^−^, 793.2905\[M − H-2Glu\]^−^, 453.1095\[M − H-3Glu-GluA\]^−^                                                                                                     Ginsenoside R~OA~                                            WsAG \< FgAG\   \[[@B52-molecules-24-01053]\]
                                                                                                                                                                                                                                                                                                                                                                                                                           VIP: 12.60\     
                                                                                                                                                                                                                                                                                                                                                                                                                           *p* \< 0.001    

  47 \*      9.54         C~41~H~70~O~14~      786.4775               786.4766               1.1                831.4775\[M + HCOO\]^−^, 767.4297\[M − H-H~2~O\]^−^, 653.4318\[M − H-Xyl\]^−^, 491.2015\[M − H-Glu-Xyl\]^−^                                                                                                                                   Majonoside R~2~                                              WsAG \> FgAG\   \[[@B39-molecules-24-01053]\]
                                                                                                                                                                                                                                                                                                                                                                                                                           VIP: 25.80\     
                                                                                                                                                                                                                                                                                                                                                                                                                           *p* \< 0.001    

  48         9.61         C~48~H~80~O~19~      960.5285               960.5294               −0.9               1005.5267\[M + HCOO\]^−^, 941.5316\[M − H-H~2~O\]^−^, 797.4287\[M − H-Glu\]^−^, 635.3221\[M − H-2Glu\]^−^, 473.2684\[M − H-3Glu\]^−^                                                                                                          Notoginsenoside G                                            WsAG, FgAG      \[[@B42-molecules-24-01053]\]

  49         9.68         C~42~H~72~O~14~      800.4922               800.4922               0.0                845.4904\[M + HCOO\]^−^, 799.4844\[M − H\]^−^, 783.2451\[M − H-Rha\]^−^, 621.3547\[M − H-Glu-Rha\]^−^                                                                                                                                         Pseudo-ginsenoside F~11~                                     WsAG, FgAG      s

  50         9.73         C~36~H~62~O~10~      654.4340               654.4343               −0.4               699.4322\[M + HCOO\]^−^, 653.4262\[M − H\]^−^, 635.4312\[M − H-H~2~O\]^−^, 491.3254\[M − H-Glu\]^−^                                                                                                                                           Pseudo-ginsenoside RT~5~                                     WsAG, FgAG      s

  51         9.78         C~36~H~62~O~10~      654.4337               654.4343               −0.9               655.4410\[M + H\]^+^, 599.4418\[M − H-3H~2~O\]^+^, 493.3437\[M − H-Glu\]^+^, 457.2651\[M − H-Glu-2H~2~O\]^+^                                                                                                                                  Pseudo-ginsenoside RT~4~                                     WsAG, FgAG      \[[@B39-molecules-24-01053]\]

  52         9.82         C~59~H~100~O~27~     1240.6458              1240.6452              0.5                1239.6380\[M − H\]^−^, 1107.6376\[M − H-Xyl\]^−^, 954.6930\[M − H-Xyl-Glu\]^−^, 783.4833\[M − H-Xyl-2Glu\]^−^, 621.4431\[M − H-Xyl-3Glu\]^−^, 459.4943\[M − H-Xyl-4Glu\]^−^                                                                   Ginsenoside Ra~3~                                            WsAG, FgAG      \[[@B53-molecules-24-01053]\]

  53         9.96         C~41~H~70~O~13~      770.4810               770.4816               −0.8               815.4804\[M + HCOO\]^−^, 751.4804\[M − H-H~2~O\]^−^, 637.4904\[M − H-Ara\]^−^, 475.3804\[M − H-Glu-Ara\]^−^                                                                                                                                   Ginsenoside F~5~                                             WsAG, FgAG      \[[@B39-molecules-24-01053]\]

  54         9.98         C~58~H~98~O~26~      1210.6350              1210.6346              0.3                1209.6272\[M − H\]^−^, 1077.5814\[M − H-Xyl\]^−^, 945.4706\[M − H-Xyl-Ara\]^−^, 783.4803\[M − H-Xyl-Ara-Glu\]^−^, 459.4799\[M − H-Xyl-Ara-3Glu\]^−^                                                                                           Ginsenoside Ra~2~                                            WsAG, FgAG      \[[@B53-molecules-24-01053]\]

  55         10.02        C~41~H~66~O~11~      734.4590               734.4605               −2.1               735.4663\[M + H\]^+^, 589.3646\[M + H-Rha\]^+^, 457.3705\[M + H-Rha-Ara\]^+^, 441.5712\[M + H-Rha-Ara-HCOOH\]^+^                                                                                                                              Eleutheroside K                                              WsAG, FgAG      \[[@B54-molecules-24-01053]\]

  56         10.04        C~48~H~80~O~18~      944.5320               944.5345               −2.6               989.5302\[M + HCOO\]^−^, 943.5263\[M − H\]^−^, 781.4839\[M − H-Glu\]^−^, 619.4206\[M − H-2Glu\]^−^, 457.5701\[M − H-3Glu\]^−^                                                                                                                 Quinquenoside L~6~                                           WsAG, FgAG      \-

  57         10.07        C~30~H~48~O~2~       440.3638               440.3654               −3.6               441.3717\[M + H\]^+^, 394.3508\[M + H-H~2~O-CHO\]^+^, 328.3504\[M + H-CHO-C~6~H~12~\]^+^, 219.1792\[M + H-C~15~H~26~O\]^+^, 205.1619\[M + H-H~2~O-C~15~H~22~O\]^+^                                                                            3*β*-Hydroxyolean-12-en-28-al                                WsAG, FgAG      a

  58         10.14        C~59~H~100~O~27~     1240.6452              1240.6462              0.8                1285.6444\[M + HCOO\]^−^, 1107.5976\[M − H-Xyl\]^−^, 945.4900\[M − H-Xyl-Glu\]^−^, 783.4835\[M − H-Xyl-2Glu\]^−^, 459.4929\[M − H-Xyl-4Glu\]^−^                                                                                               Notoginsenoside Fa                                           WsAG, FgAG      \[[@B53-molecules-24-01053]\]

  59         10.24        C~54~H~92~O~23~      1108.6039              1108.6029              0.8                1153.6021\[M + HCOO\]^−^, 1107.5961\[M − H\]^−^, 943.5414\[M − H-Glu\]^−^, 763.4784\[M − H-2Glu\]^−^, 615.4417\[M − H-3Glu\]^−^                                                                                                               Ginsenoside Rb~1~                                            WsAG, FgAG      s

  60         10.24        C~30~H~48~O          424.3692               424.3705               −3.1               425.3765\[M + H\]^+^, 409.3102\[M + H-H~2~O\]^+^, 371.3759\[M + H-CH~3~-C~3~H~5~\]^+^, 189.1614\[M + H-C~16~H~26~O\]^+^, 205.1775\[M + H-C~15~H~26~O\]^+^                                                                                     Olean-18-en-3-one                                            WsAG, FgAG      \[[@B55-molecules-24-01053]\]

  61         10.31        C~57~H~94~O~26~      1194.6054              1194.6033              1.7                1193.5981\[M − H\]^−^, 1077.5402\[M − H-mal\]^−^, 945.5097\[M − H-mal-Glu\]^−^, 783.4906\[M − H-mal-2Glu\]^−^, 621.4906\[M − H-mal-3Glu\]^−^                                                                                                  Malonyl-ginsenoside Rb~1~                                    WsAG, FgAG      \[[@B53-molecules-24-01053]\]

  62         10.33        C~42~H~72~O~13~      784.4975               784.4973               0.3                829.4957\[M + HCOO\]^−^, 768.4744\[M − H-CH~3~\]^−^, 635.4330\[M − H-Rha\]^−^, 471.3782\[M − H-Glu-Rha\]^−^                                                                                                                                   20(*R*)-Ginsenoside Rg~2~                                    WsAG, FgAG      s

  63         10.35        C~36~H~62~O~9~       638.4391               638.4394               −0.4               683.4373\[M + HCOO\]^−^, 637.4313\[M − H\]^−^, 475.2658\[M − H-Glu\]^−^, 457.2235\[M − H-Glu-H~2~O\]^−^                                                                                                                                       20(*S*)-Ginsenoside Rh~1~                                    WsAG, FgAG      s

  64         10.36        C~41~H~70~O~13~      770.4817               770.4816               0.0                815.4799\[M + HCOO\]^−^, 678.4450\[M − H-2H~2~O-C~4~H~7~\]^−^, 637.4321\[M − H-Ara\]^−^, 590.2706\[M − H-C~4~H~7~-C~9~H~16~\]^−^, 475.2622\[M − H-Glu-Ara\]^−^                                                                                Ginsenoside F~3~                                             WsAG, FgAG      \[[@B39-molecules-24-01053]\]

  65         10.39        C~53~H~90~O~22~      1078.5931              1078.5924              0.6                1123.5913\[M + HCOO\]^−^, 943.5423\[M − H-Araf\]^−^, 854.4890\[M − H-H~2~O-Araf-C~4~H~7~\]^−^, 763.4850\[M − H-Glu-Araf\]^−^                                                                                                                  Ginsenoside Rc                                               WsAG, FgAG      s

  66         10.42        C~36~H~60~O~8~       620.4276               620.4288               −1.9               621.4349\[M + H\]^+^, 603.4238\[M + H-H~2~O\]^+^, 441.3714\[M + H-Glu\]^+^, 423.3612\[M + H-Glu-H~2~O\]^+^, 350.2971\[M + H-Glu-2H~2~O-C~4~H~7~\]^+^, 341.1160\[M + H-Glu-C~6~H~12~O\]^+^                                                     Ginsenoside Rh~4~                                            WsAG, FgAG      \[[@B56-molecules-24-01053]\]

  67         10.46        C~58~H~98~O~26~      1210.6353              1210.6346              0.6                1209.6275\[M − H\]^−^, 1077.5914\[M − H-Xyl\]^−^, 945.4807\[M − H-Xyl-Ara\]^−^, 783.4687\[M − H-Xyl-Ara-Glu\]^−^, 459.4329\[M − H-Xyl-Ara-3Glu\]^−^                                                                                           Ginsenoside Ra~1~                                            WsAG, FgAG      \[[@B53-molecules-24-01053]\]

  68         10.58        C~56~H~92~O~25~      1164.5932              1164.5928              0.3                1163.5859\[M − H\]^−^, 1119.5976\[M − H-CO~2~\]^−^, 1077.6021\[M − H-Mal\]^−^, 1031.5694\[M − H-Araf\]^−^, 945.4900\[M − H-Araf-Mal\]^−^, 783.4835\[M − H-Glu-Araf-Mal\]^−^                                                                   Malonyl-ginsenoside Rc                                       WsAG, FgAG      \[[@B53-molecules-24-01053]\]

  69         10.62        C~48~H~76~O~19~      956.4976               956.4981               −0.5               955.4903\[M − H\]^−^, 783.4214\[M − H-GluA\]^−^, 631.4157\[M − H-2Glu\]^−^, 459.4174\[M − H-2Glu-GluA\]^−^                                                                                                                                    Ginsenoside Ro                                               WsAG, FgAG      s

  70 ^\#^    10.69        C~30~H~46~O~2~       438.3486               438.3498               −2.7               439.3563\[M + H\]^+^, 424.3600\[M + H-CH~3~\]^+^, 411.1114\[M + H-CO\]^+^, 233.1676\[M + H-C~15~H~24~\]^+^, 205.1928\[M + H-C~15~H~22~O~2~\]^+^, 190.1778\[M + H-C~16~H~23~O~2~\]^+^                                                          3,11-dioxo-*β*-amyrene                                       WsAG \< FgAG\   \[[@B57-molecules-24-01053]\]
                                                                                                                                                                                                                                                                                                                                                                                                                           VIP: 6.49\      
                                                                                                                                                                                                                                                                                                                                                                                                                           *p* \< 0.001    

  71         10.70        C~53~H~84~O~23~      1088.5402              1088.5403              −0.1               1087.5326\[M − H\]^−^, 955.5235\[M − H-Ara\]^−^, 925.4610\[M − H-Glu\]^−^, 793.2350\[M − H-Ara-Glu\]^−^, 455.4611\[M − H-Ara-2Glu-GluA\]^−^                                                                                                   Stipuleanoside R2                                            WsAG, FgAG      \[[@B39-molecules-24-01053]\]

  72         10.78        C~53~H~90~O~22~      1078.5924              1078.5924              0.0                1123.5906\[M + HCOO\]^−^, 913.5403\[M − H-Glu\]^−^, 779.4886\[M − H-Glu-Ara\]^−^, 615.4431\[M − H-2Glu-Ara\]^−^                                                                                                                               Ginsenoside Rb~2~                                            WsAG, FgAG      s

  73         10.79        C~53~H~90~O~22~      1078.5924              1078.5924              0.0                1123.5320\[M + HCOO\]^−^, 913.4581\[M − H-Glu\]^−^, 779.3696\[M − H-Glu-Xyl\]^−^, 615.4912\[M − H-2Glu-Xyl\]^−^, 451.3672\[M − H-3Glu-Xyl\]^−^                                                                                                Ginsenoside Rb~3~                                            WsAG, FgAG      s

  74         10.89        C~55~H~92~O~23~      1120.6009              1120.6029              −1.8               1165.5991\[M + HCOO\]^−^, 1077.3151\[M − H-Xyl\]^−^, 945.5076\[M − H-Ara-Xyl\]^−^, 783.3942\[M − H-Ara-Xyl-Glu\]^−^, 621.4742\[M − H-Ara-Xyl-2Glu\]^−^                                                                                        Notoginsenoside Fc                                           WsAG, FgAG      \[[@B53-molecules-24-01053]\]

  75         10.94        C~56~H~92~O~25~      1164.5937              1164.5928              0.8                1163.5864\[M − H\]^−^, 1077.5570\[M − H-Mal\]^−^, 945.5302\[M − H-Ara-Mal\]^−^, 783.4540\[M − H-Glu-Ara-Mal\]^−^, 621.4570\[M − H-2Glu-Ara-Mal\]^−^                                                                                           Malonyl-ginsenoside Rb~2~                                    WsAG, FgAG      \[[@B53-molecules-24-01053]\]

  76         11.01        C~56~H~94~O~24~      1150.6138              1150.6135              0.3                1195.6120\[M + HCOO\]^−^, 1149.6060\[M − H\]^−^, 1107.4997\[M − H-Ac\]^−^, 987.4976\[M − H-Glu\]^−^, 945.6047\[M − H-Glu-Ac\]^−^, 783.4864\[M − H-2Glu-Ac\]^−^                                                                                Quinquenoside R~1~                                           WsAG, FgAG      \[[@B53-molecules-24-01053]\]

  77         11.02        C~47~H~74~O~18~      926.4864               926.4875               −1.2               925.4791\[M − H\]^−^, 793.4272\[M − H-Ara\]^−^, 612.3784\[M − H-GluA-Ara\]^−^, 540.3784\[M − H-Glu-C~14~H~21~O\]^−^, 455.2841\[M − H-Glu-Ara-GluA\]^−^                                                                                        Chikusetsu saponin IV                                        WsAG, FgAG      \[[@B39-molecules-24-01053]\]

  78         11.14        C~56~H~92~O~25~      1164.4967              1164.4958              0.8                1163.4925\[M − H\]^−^, 1077.5760\[M − H-Mal\]^−^, 945.5503\[M − H-Mal-Xyl\]^−^, 783.4735\[M − H-Mal-Xyl-Glu\]^−^, 621.4269\[M − H-Mal-Xyl-2Glu\]^−^                                                                                           Malonyl-ginsenoside Rb~3~                                    WsAG, FgAG      \[[@B53-molecules-24-01053]\]

  79         11.16        C~36~H~62~O~9~       638.4395               638.4394               0.2                683.4366\[M + HCOO\]^−^, 637.4317\[M − H\]^−^, 475.2574\[M − H-Glu\]^−^, 457.2147\[M − H-Glu-H~2~O\]^−^                                                                                                                                       20(*R*)-ginsenoside Rh~1~                                    WsAG, FgAG      s

  80         11.18        C~43~H~72~O~15~      828.4864               828.4871               −0.8               873.4846\[M + HCOO\]^−^, 784.4798\[M − H-COCH~3~\]^−^, 695.2912\[M − H-Xyl\]^−^, 491.4938\[M − H-Xyl-Glu-Ac\]^−^, 455.2535\[M − H-Xyl-Glu-Ac-2H~2~O\]^−^                                                                                      Vinaginsenoside R~2~                                         WsAG, FgAG      \[[@B39-molecules-24-01053]\]

  81 ^\#^    11.20        C~48~H~82~O~17~      930.5546               930.5552               −0.7               929.5474\[M − H\]^−^, 767.4642\[M − H-Glu\]^−^, 605.4365\[M − H-2Glu\]^−^, 443.1196\[M − H-3Glu\]^−^                                                                                                                                          Vinaginsenosides R~3~                                        WsAG \< FgAG\   \[[@B58-molecules-24-01053],[@B59-molecules-24-01053]\]
                                                                                                                                                                                                                                                                                                                                                                                                                           VIP: 7.60\      
                                                                                                                                                                                                                                                                                                                                                                                                                           *p* \< 0.001    

  82         11.34        C~42~H~66~O~14~      794.4447               794.4453               −0.8               793.4368\[M − H\]^−^, 631.3279\[M − H-Glu\]^−^, 613.4222\[M − H-Glu-H~2~O\]^−^, 569.2927\[M − H-Glu-HCOOH\]^−^, 455.1562\[M − H-Glu-GluA\]^−^                                                                                                 Chikusetsu saponin II                                        WsAG, FgAG      \[[@B39-molecules-24-01053]\]

  83         11.36        C~48~H~82~O~18~      946.5508               946.5501               0.7                991.5490\[M + HCOO\]^−^, 945.5430\[M − H\]^−^, 783.5147\[M − H-Glu\]^−^, 459.3241\[M − H-3Glu\]^−^                                                                                                                                            Ginsenoside Rd                                               WsAG, FgAG      s

  84         11.39        C~55~H~92~O~23~      1120.6029              1120.6049              1.7                1119.5941\[M − H\]^−^, 1077.5699\[M − H-Ac\]^−^, 943.4874\[M − H-Ac-Ara\]^−^, 779.1224\[M − H-Ac-Ara-Glu\]^−^, 451.2649\[M − H-Ac-Ara-3Glu\]^−^                                                                                               Ginsenoside Rs~1~                                            WsAG, FgAG      s

  85         11.52        C~51~H~84~O~21~      1032.5503              1032.5505              −0.2               1031.5425\[M − H\]^−^, 987.5520\[M − H-CO~2~\]^−^, 945.5192\[M − H-mal\]^−^, 783.3540\[M − H-mal-Glu\]^−^, 621.2570\[M − H-mal-2Glu\]^−^, 459.3458\[M − H-mal-3Glu\]^−^                                                                       Malonyl-ginsenoside Rd                                       WsAG, FgAG      \[[@B53-molecules-24-01053]\]

  86         11.70        C~55~H~92~O~23~      1120.6039              1120.6029              0.8                1165.6021\[M + HCOO\]^−^, 1119.5961\[M − H\]^−^, 987.3684\[M − H-Ara\]^−^, 914.4587\[M − H-Glu-Ac\]^−^, 458.5471\[M − H-3Glu-Ara-Ac\]^−^                                                                                                      Ginsenoside Rs~2~                                            WsAG, FgAG      s

  87         11.88        C~48~H~82~O~18~      946.5501               946.5500               −0.1               991.5482\[M + HCOO\]^−^, 783.4871\[M − H-Glu\]^−^, 603.4416\[M − H-2Glu\]^−^                                                                                                                                                                  Gypenoside XVII                                              WsAG, FgAG      s

  88         12.20        C~19~H~36~O~5~       344.2565               344.2563               0.6                343.2486\[M − H\]^−^, 329.0232\[M − H-CH~3~\]^−^, 311.2112\[M − H-H~2~O-CH~3~\]^−^, 294.1609\[M − H-H~2~O-OCH~3~\]^−^, 255.1494\[M − H-OCH~3~-C~4~H~9~\]^−^, 242.1610\[M − H-OCH~3~-C~5~H~11~\]^−^, 228.2523\[M − H-OCH~3~-C~6~H~12~\]^−^     Methyl-9,10,11-trihydroxy-12- octadecenoate                  WsAG, FgAG      \[[@B60-molecules-24-01053]\]

  89         12.27        C~47~H~80~O~17~      916.5398               916.5396               0.2                961.5380\[M + HCOO\]^−^, 866.4901\[M − H-H~2~O-CH~2~OH\]^−^, 783.4749\[M − H-Ara\]^−^, 753.4664\[M − H-Glu\]^−^, 621.4616\[M − H-Glu-Ara\]^−^, 459.4008\[M − H-2Glu-Ara\]^−^                                                                  Notoginsenoside Fe                                           WsAG, FgAG      \[[@B39-molecules-24-01053]\]

  90         12.38        C~50~H~84~O~19~      988.5594               988.5607               −1.3               1033.5576\[M + HCOO\]^−^, 987.5539\[M − H\]^−^, 945.5428\[M − H-COCH~3~\]^−^, 809.4326\[M − H-2H~2~O-C~8~H~14~O~2~\]^−^, 797.4813\[M − H-Glu-C~2~H~4~\]^−^                                                                                    Quinquenoside III                                            WsAG, FgAG      \[[@B61-molecules-24-01053]\]

  91 ^\#^    12.48        C~47~H~80~O~17~      916.5385               916.5396               −1.1               961.5385\[M + HCOO\]^−^, 900.5146\[M − H-CH~3~\]^−^, 783.49.6\[M − H-Ara\]^−^, 630.4290\[M − H-Glu-2H~2~O-C~5~H~9~\]^−^, 621.3500\[M − H-Glu-Ara\]^−^, 459.2328\[M − H-2Glu-Ara\]^−^                                                          Chikusetsu saponin III                                       WsAG \< FgAG\   \[[@B39-molecules-24-01053]\]
                                                                                                                                                                                                                                                                                                                                                                                                                           VIP: 12.78\     
                                                                                                                                                                                                                                                                                                                                                                                                                           *p* \< 0.001    

  92         12.57        C~30~H~46~O~2~       766.4855               766.4867               −1.6               767.4928\[M + H\]^+^, 749.3674\[M + H-H~2~O\]^+^, 621.2398\[M + H-Rha\]^+^, 459.2280\[M + H-Glu-Rha\]^+^, 207.1780\[M + H-Glu-Rha-C~16~H~26~O\]^+^                                                                                            (20*E*)-Ginsenoside F~4~                                     WsAG, FgAG      \[[@B62-molecules-24-01053]\]

  93         12.68        C~47~H~80~O~17~      916.5399               916.5396               0.3                961.5381\[M + HCOO\]^−^, 814.4616\[M − H-H~2~O-C~6~H~11~\]^−^, 783.4923\[M − H-Xyl\]^−^, 621.4390\[M − H-Glu-Xyl\]^−^                                                                                                                         Gypenoside IX                                                WsAG, FgAG      \[[@B53-molecules-24-01053]\]

  94         13.14        C~42~H~70~O~14~      798.4748               798.4765               −2.1               797.4676\[M − H\]^−^, 651.4246\[M − H-Rha\]^−^, 489.4158\[M − H-Glu-Rha\]^−^                                                                                                                                                                  Ginsenoside Rg~8~                                            WsAG, FgAG      \[[@B63-molecules-24-01053]\]

  95         13.18        C~52~H~86~O~19~      1014.5756              1014.5763              −0.6               1059.5738\[M + HCOO\]^−^, 1013.5685\[M − H\]^−^, 945.5933\[M − H-C~4~H~5~O\]^−^, 851.4510\[M − H-Glu\]^−^, 833.4903\[M − H-Glu-H~2~O\]^−^, 620.2875\[M − H-2Glu-C~4~H~5~O\]^−^, 458.2663\[M − H-3Glu-C~4~H~5~O\]^−^                           Quinquenoside I                                              WsAG, FgAG      \[[@B61-molecules-24-01053]\]

  96         13.31        C~48~H~82~O~17~      930.5548               930.5552               −0.4               929.5470\[M − H\]^−^, 783.4642\[M − H-Rha\]^−^, 767.4695\[M − H-Glu\]^−^, 621.4365\[M − H-Glu-Rha\]^−^, 459.3956\[M − H-2Glu-Rha\]^−^                                                                                                         Gypenoside X                                                 WsAG, FgAG      \-

  97         13.43        C~42~H~70~O~12~      766.4861               766.4867               −0.8               765.4783\[M + HCOO\]^−^, 610.2361\[M − H-CH~2~OH-C~8~H~13~-CH~3~\]^−^, 603.2375\[M − H-Glu\]^−^, 441.1811\[M − H-2Glu\]^−^, 340.2323\[M − H-C~30~H~49~O\]^−^                                                                                  Ginsenoside Rk~1~                                            WsAG, FgAG      \[[@B39-molecules-24-01053]\]

  98         13.50        C~47~H~74~O~18~      926.4862               926.4875               −1.4               925.4789\[M − H\]^−^, 793.4879\[M − H-Ara\]^−^, 731.4457 \[M − H-Ara-HCOOH\]^−^, 727.4338\[M − H-Glu-H~2~O\]^−^, 659.4254\[M − H-Glu-C~3~H~4~-HCOOH\]^−^, 569.4945 \[M − H-Ara-Glu-HCOOH\]^−^, 455. 4979 \[M − H-Ara- Glu-GluA\]^−^           Chikusetsu saponin Ib                                        WsAG, FgAG      \[[@B39-molecules-24-01053]\]

  99 ^\#^    13.52        C~42~H~72~O~13~      784.4974               784.4973               −0.1               783.4896\[M − H\]^−^, 737.4755\[M − H-CH~2~OH-CH~3~\]^−^, 660.4330\[M − H-3H~2~O-C~5~H~9~\]^−^, 621.4361\[M − H-Glu\]^−^, 459.3782\[M − H-2Glu\]^−^                                                                                           Ginsenoside F~2~                                             WsAG \< FgAG\   \[[@B39-molecules-24-01053]\]
                                                                                                                                                                                                                                                                                                                                                                                                                           VIP: 17.01\     
                                                                                                                                                                                                                                                                                                                                                                                                                           *p* \< 0.001    

  100        13.57        C~18~H~30~O~4~       310.2141               310.2144               −1.0               309.2068\[M − H\]^−^, 291.1960\[M − H-H~2~O\]^−^, 185.1181\[M − H-COOH-C~6~H~9~\]^−^, 171.1024\[M − H-CH~2~COOH-C~6~H~9~\]^−^                                                                                                                 13S-hydroperoxy-9Z,11E,15Z- octadecatrienoic acid            WsAG, FgAG      \[[@B64-molecules-24-01053]\]

  101        13.62        C~36~H~60~O~7~       604.4334               604.4339               −0.8               605.4407\[M + H\]^+^, 586.4285\[M + H-H~2~O\]^+^, 443.3860\[M + H-Glu\]^+^, 405.3657\[M + H-Glu-H~2~O\]^+^, 333.0939\[M + H-2H~2~O-C~16~H~26~O\]^+^, 296.1006\[M + H-Glu-H~2~O-C~8~H~13~\]^+^                                                 Isoginsenoside Rh~3~                                         WsAG, FgAG      \[[@B65-molecules-24-01053]\]

  102 \*     13.93        C~42~H~66~O~14~      794.4449               794.4453               −0.5               793.4387\[M − H\]^−^, 613.3751\[M − H-Glu\]^−^, 569.3830\[M − H-Glu-H~2~O-CO~2~\]^−^                                                                                                                                                          Chikusetsusaponin Iva                                        WsAG \> FgAG\   \[[@B53-molecules-24-01053]\]
                                                                                                                                                                                                                                                                                                                                                                                                                           VIP:16.17\      
                                                                                                                                                                                                                                                                                                                                                                                                                           *p* \< 0.001    

  103        14.51        C~42~H~72~O~13~      784.4967               784.4973               −0.7               829.4951\[M + HCOO\]^−^, 783.4892\[M − H\]^−^, 621.4442\[M − H-Glu\]^−^, 459.3684\[M − H-2Glu\]^−^                                                                                                                                            20(*R*)-Ginsenoside Rg~3~                                    WsAG, FgAG      s

  104        14.64        C~17~H~30~O~2~       266.2246               266.2246               −0.1               311.2228\[M + HCOO\]^−^, 168.1023\[M − H-C~7~H~13~\]^−^, 154.1074\[M − H-C~8~H~15~\]^−^, 137.2250\[M − H-C~7~H~13~-OCH~3~\]^−^, 115.0352\[M − H-C~4~H~7~-C~6~H~9~O\]^−^, 96.0352\[M − H-C~11~H~21~O\]^−^                                      5-Hexenoic acid, 10-undecenyl ester                          WsAG, FgAG      a

  105 ^\#^   14.74        C~18~H~28~O~2~       276.2081               276.2089               −2.9               277.2156\[M + H\]^+^, 150.1312\[M + H-C~7~H~11~O~2~\]^+^, 137.0951\[M + H-H~2~O-C~9~H~14~\]^+^, 110.1017\[M + H-C~10~H~15~O~2~\]^+^                                                                                                           Palmitoleic acid                                             WsAG \< FgAG\   s
                                                                                                                                                                                                                                                                                                                                                                                                                           VIP: 8.57\      
                                                                                                                                                                                                                                                                                                                                                                                                                           *p* \< 0.001    

  106        14.75        C~42~H~72~O~13~      784.4940               784.4973               −4.1               829.4951\[M + HCOO\]^−^, 783.4865\[M − H\]^−^, 621.4942\[M − H-Glu\]^−^, 459.4578\[M − H-2Glu\]^−^, 441.5214\[M − H-2Glu-H~2~O\]^−^                                                                                                           20(*S*)-Ginsenoside Rg~3~                                    WsAG, FgAG      s

  107        14.90        C~41~H~70~O~12~      754.4874               754.4867               0.8                799.4856\[M + HCOO\]^−^, 621.3141\[M − H-Xyl\]^−^, 459.3887\[M − H-Glu-Xyl\]^−^, 351.2556\[M − H-Xyl-H~2~O-C~16~H~28~O~2~\]^−^, 275.1442\[M − H-Glu-Xyl-2C~6~H~11~\]^−^                                                                       Gypenoside XIII                                              WsAG, FgAG      \[[@B66-molecules-24-01053]\]

  108        14.98        C~41~H~64~O~13~      764.4345               764.4347               −0.3               763.4272\[M − H\]^−^, 613.3766\[M − H-Xyl\]^−^, 569.3856\[M − H-Xyl-HCOOH\]^−^                                                                                                                                                                Pseudo-ginsenoside Rp~1~                                     WsAG, FgAG      \[[@B39-molecules-24-01053]\]

  109        15.05        C~17~H~30~O~2~       266.2244               266.2246               −0.7               311.2226\[M + HCOO\]^−^, 222.1128\[M − H-C~3~H~7~\]^−^, 139.0826\[M − H-C~9~H~19~\]^−^, 127.1127\[M − H-C~8~H~11~O~2~\]^−^                                                                                                                    (2E,4E)-Hydroprene                                           WsAG, FgAG      a

  110        15.75        C~43~H~68~O~14~      808.4610               808.4609               0.1                807.4532\[M − H\]^−^, 609.3820\[M − H-Glu-H~2~O\]^−^, 455.3519\[M − H-Glu-Glu acid methyl ester\]^−^, 319.1792\[M − H-Glu acid methyl ester-C~21~H~32~\]^−^                                                                                   Chikusetsusaponin IVa methyl ester                           WsAG, FgAG      \[[@B39-molecules-24-01053]\]

  111        15.98        C~18~H~30~O~3~       294.2194               294.2195               −0.3               293.2122\[M − H\]^−^, 275.2013\[M − H-H~2~O\]^−^, 171.1024\[M − H-C~9~H~15~\]^−^, 121.1020\[M − H-C~9~H~15~O~3~\]^−^                                                                                                                          (*E*,*E*)-9-Oxooctadeca-10,12-dienoic acid                   WsAG, FgAG      \[[@B34-molecules-24-01053]\]

  112 \*     16.90        C~36~H~62~O~8~       622.4431               622.4445               −2.1               667.4442\[M + HCOO\]^−^, 621.4360\[M − H\]^−^, 459.2656\[M − H-Glu\]^−^, 441.4772\[M − H-Glu-H~2~O\]^−^                                                                                                                                       Ginsenoside Rh~2~                                            WsAG \> FgAG\   s
                                                                                                                                                                                                                                                                                                                                                                                                                           VIP: 4.68\      
                                                                                                                                                                                                                                                                                                                                                                                                                           *p* = 0.0032    

  113        17.34        C~18~H~32~O~3~       296.2347               296.2351               1.4                295.2274\[M − H\]^−^, 278.2172\[M − H-H~2~O\]^−^, 233.2273\[M − H-HCOOH-O\]^−^, 184.1182\[M − H-C~8~H~15~\]^−^, 171.1023\[M − H-C~9~H~16~\]^−^, 148.1125\[M − H-C~8~H~15~O~2~\]^−^, 125.1174\[M − H-H~2~O-C~10~H~17~O\]^−^                    9-Hydroxyoctadeca-10,12-dienoic acid                         WsAG, FgAG      \[[@B67-molecules-24-01053]\]

  114        17.37        C~42~H~70~O~12~      766.4860               766.4867               −0.9               811.4933\[M + HCOO\]^−^, 747.4834\[M − H-H~2~O\]^−^, 603.4833\[M − H-Glu\]^−^, 585.4309\[M − H-Glu\]^−^, 459.0768\[M − H-Glu-Rha\]^−^, 421.4457\[M − H-Glu-Rha\]^−^                                                                           Ginsenoside Rg~5~                                            WsAG, FgAG      \[[@B53-molecules-24-01053]\]

  115 ^\#^   17.45        C~18~H~30~O~2~       278.2245               278.2246               −0.1               279.2321\[M + H\]^+^, 218.1936\[M + H-HCOOH-CH~3~\]^+^, 184.1479\[M + H-C~7~H~11~\]^+^                                                                                                                                                        *α*-Linolenic Acid                                           WsAG \< FgAG\   s
                                                                                                                                                                                                                                                                                                                                                                                                                           VIP: 5.24\      
                                                                                                                                                                                                                                                                                                                                                                                                                           *p* \< 0.001    

  116        18.24        C~32~H~50~O~4~       498.3722               498.3709               2.4                521.3614\[M+Na\]^+^, 484.3365\[M + H-CH~3~\]^+^, 439.3322\[M + H-C~2~H~3~O~2~\]^+^, 303.3080\[M-C~12~H~20~O~2~\]^+^, 263.2783\[M-C~15~H~24~O~2~\]^+^, 248.2610\[M + H-C~16~H~26~O~2~\]^+^, 203.0991\[M + H-C~2~H~3~O~2~-C~15~H~22~O~2~\]^+^   3-*O*-Acetyloleanolic acid                                   WsAG, FgAG      a

  117 \*     18.50        C~19~H~24~O~2~       284.1773               284.1776               −1.1               285.1843\[M + H\]^+^, 259.2243\[M + H-C~2~H~2~\]^+^, 243.1701\[M + H-C~2~H~2~O\]^+^, 159.1308\[M + H-C~8~H~13~O\]^+^, 122.1168\[M + H-C~11~H~11~O\]^+^                                                                                        Androsta-1,4-diene-3,17-dione                                WsAG \> FgAG\   a
                                                                                                                                                                                                                                                                                                                                                                                                                           VIP: 6.16\      
                                                                                                                                                                                                                                                                                                                                                                                                                           *p* \< 0.001    

  118        19.97        C~16~H~28~O~3~       268.2039               268.2038               0.4                291.1950\[M+Na\]^+^, 223.1536\[M + H-HCOOH\]^+^, 123.0441\[M + H-H~2~O-C~7~H~13~O~2~\]^+^, 95.0141\[M + H-C~4~H~9~O-C~5~H~9~O~2~\]                                                                                                            13-Hydroxy-9,11-hexadecanedioic acid                         WsAG, FgAG      \[[@B34-molecules-24-01053]\]

  119        20.15        C~17~H~24~O~2~       260.1766               260.1776               −3.8               261.1839\[M + H\]^+^, 243.1708\[M + H-H~2~O\]^+^, 221.1479\[M + H-CH~3~-C~2~H~3~\]^+^, 159.0791\[M + H-H~2~O-C~6~H~13~\]^+^                                                                                                                   Panaxydol                                                    WsAG, FgAG      \[[@B68-molecules-24-01053]\]

  120        20.49        C~17~H~26~O~3~       280.3138               280.3130               3.3                303.3030\[M+Na\]^+^, 252.2401\[M + H-C~2~H~5~\]^+^, 149.1310\[M + H-C~10~H~21~\]^+^,140.1322\[M + H-C~10~H~21~\]^+^, 97.1025\[M + H-C~13~H~27~\]^+^                                                                                           1-Eicosene                                                   WsAG, FgAG      a

  121        22.88        C~19~H~38~O~4~       330.2766               330.2770               −1.2               353.2658\[M+Na\]^+^, 313.2725\[M + H-H~2~O\]^+^, 280.2603\[M + H-2H~2~O-CH~3~\]^+^, 239.2352\[M + H-C~3~H~7~O~3~\]^+^, 99.0871\[M + H-C~4~H~7~O~4~-C~8~H~17~\]^+^                                                                             Monopalmitin                                                 WsAG, FgAG      \[[@B30-molecules-24-01053]\]
  --------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------

\* Characteristic component in WsAG. ^\#^ Characteristic component in FgAG. ^s^ Identified with a standard, ^a^ Compared with spectral data obtained from Wiley Subscription Services, Inc. (New York, NY, USA).
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###### 

Details of FgAG and WsAG samples.

  ------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------
  Species and the Morphological Features                                                                                                                                                                                                      Source                                     Growth Year        Collection Time    Batch No.
  ------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------- ------------------------------------------ ------------------ ------------------ -------------
  FgAGs\                                                                                                                                                                                                                                      Ji'an City, Jilin Province, China          3, 4               2017.09--2017.10   FgAG1, 11
  *Main roots 9\~15 cm (length) × 1.5\~3.0 cm (diameter); 2\~3 branch roots with diameters of 2\~3.5 cm; fibrous roots with diameters of 0.1\~0.2 cm; 3\~4 stem scars in rhizomes; no adventitious roots.*                                                                                                                     

  Fusong County, Jilin Province, China                                                                                                                                                                                                        3, 4                                       2017.09--2017.10   FgAG2, 12          

  Tonghua City, Jilin Province, China                                                                                                                                                                                                         3, 4                                       2017.09--2017.10   FgAG3,13           

  Jingyu Country, Jilin Province, China                                                                                                                                                                                                       3, 4                                       2017.09--2017.10   FgAG4, 14          

  Antu Country, Jilin Province, China                                                                                                                                                                                                         3, 4                                       2017.09--2017.10   FgAG5, 15          

  Hunchun City, Jilin Province, China                                                                                                                                                                                                         3, 4                                       2017.09--2017.10   FgAG6, 16          

  Helong City, Jilin Province, China                                                                                                                                                                                                          3, 4                                       2017.09--2017.10   FgAG7, 17          

  Huadian City, Jilin Province, China                                                                                                                                                                                                         3, 4                                       2017.09--2017.10   FgAG8, 18          

  Huairou District, Beijing Province, China                                                                                                                                                                                                   3, 4                                       2017.10--2017.11   FgAG9, 19          

  Wendeng Area, Shandong Province, China                                                                                                                                                                                                      3, 4                                       2017.10--2017.11   FgAG10, 20         

  WsAGs\                                                                                                                                                                                                                                      Lawton Coumtry, Michigan State, American   \>15               2017.09--2017.11   WsAG1, 3, 6
  *Main roots 5.0\~6.0 cm (length) × 1.5\~2.0 cm (diameter); 2\~3 branch roots with diameters of 0.5\~0.9 cm; fibrous roots with diameters of 0.1\~0.2 cm; 15\~25 stem scars in rhizomes; adventitious roots with diameters of 0.5\~0.8 cm*                                                                                    

  Schoharie County, Catskill region, American                                                                                                                                                                                                 \>15                                       2017.09--2017.10   WsAG2, 4, 8        

  Monongalia County, West Virginia, American                                                                                                                                                                                                  \>15                                       2017.10--2017.11   WsAG5, 7           
  ------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------
